Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» On a crash course with Celgene? Biogen inks a $544M autoimmune drug deal
On a crash course with Celgene? Biogen inks a $544M autoimmune drug deal
On a crash course with Celgene? Biogen inks a $544M autoimmune drug deal
Submitted by
admin
on September 9, 2015 - 8:12am
Source:
Fierce Biotech
News Tags:
Celgene
Biogen
autoimmune disease
MT-1303
Mitsubishi Tanabe Pharma
Headline:
On a crash course with Celgene? Biogen inks a $544M autoimmune drug deal
Do Not Allow Advertisers to Use My Personal information
